EcoDrugPlus

Glutamate Metabotropic Receptor 5

Ensembl ID : ENSCHAG00000010541
Gene Symbol: GRM5
1 Cross references
203 Possible Orthologues:

Glutamate Receptor 3-Like

Ensembl ID : ENSCHAG00000015907
Gene Symbol: LOC105912015
3 Cross references
199 Possible Orthologues:

Glutamate Receptor 4-Like

Ensembl ID : ENSCHAG00000005255
Gene Symbol: LOC105905528
3 Cross references
251 Possible Orthologues:

Glutamate Receptor Ionotropic, Nmda 1-Like

Ensembl ID : ENSCHAG00000014649
Gene Symbol: LOC105891600
3 Cross references
152 Possible Orthologues:

Glutamate Receptor, Ionotropic, Ampa 1a

Ensembl ID : ENSCHAG00000017335
Gene Symbol: GRIA1A
1 Cross references
252 Possible Orthologues:

Glutamate Receptor, Ionotropic, Ampa 1b

Ensembl ID : ENSCHAG00000001190
Gene Symbol: GRIA1B
1 Cross references
250 Possible Orthologues:

Glutamate Receptor, Ionotropic, Ampa 2a

Ensembl ID : ENSCHAG00000027466
Gene Symbol: GRIA2A
1 Cross references
244 Possible Orthologues:

Glutamate Receptor, Ionotropic, N-Methyl D-Aspartate 1a

Ensembl ID : ENSCHAG00000025691
Gene Symbol: GRIN1A
1 Cross references
204 Possible Orthologues:

Glutamate Receptor, Ionotropic, N-Methyl D-Aspartate 2b, Genome Duplicate B

Ensembl ID : ENSCHAG00000017076
Gene Symbol: GRIN2BB
1 Cross references
256 Possible Orthologues:

Glutamate Receptor, Metabotropic 3

Ensembl ID : ENSCHAG00000009888
Gene Symbol: GRM3
1 Cross references
212 Possible Orthologues:

Glutaminase

Ensembl ID : ENSCHAG00000010447
Gene Symbol: GLS
1 Cross references
166 Possible Orthologues:

Glutaminase A

Ensembl ID : ENSCHAG00000023091
Gene Symbol: GLSA
1 Cross references
235 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).